Abstract
Given that HIV-protease inhibitors (HIV-PIs) are substrates/inhibitors of the multidrug transporter ABCB1, can induce ABCB1 expression, and are used in combination with doxorubicin for AIDS-Kaposi's Sarcoma (KS) treatment, the role that ABCB1 plays in mediating multidrug resistance (MDR) in a fully transformed KS cell line (SLK) was explored.
Lingua originale | English |
---|---|
pagine (da-a) | 513-522 |
Numero di pagine | 10 |
Rivista | British Journal of Cancer |
Volume | 105 |
DOI | |
Stato di pubblicazione | Pubblicato - 2011 |
Keywords
- Antibiotics, Antineoplastic
- Blotting, Western
- Cell Line, Tumor
- Doxorubicin
- Drug Resistance, Multiple
- Drug Resistance, Neoplasm
- Drug Synergism
- Flow Cytometry
- Fluorescent Antibody Technique
- Gene Expression Regulation, Neoplastic
- HIV Infections
- HIV Protease Inhibitors
- Humans
- Indinavir
- Lopinavir
- Nelfinavir
- Oligopeptides
- P-Glycoprotein
- Pyridines
- Pyrimidinones
- Reverse Transcriptase Polymerase Chain Reaction
- Ritonavir
- Sarcoma, Kaposi
- Treatment Outcome